Skip to main content

Animations

MJFF Publications

5201 - 5210 of 7915 Results
Title
Year
  • Year
  • 2019
  • 2019
  • 2019
  • 2019
  • 2019
  • 2019
  • 2019
  • 2019
  • 2019
  • 2019
  • RESTRICTED
    Title: Revisiting protein aggregation as pathogenic in sporadic Parkinson and Alzheimer diseases
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.0000000000006926
    Citation Count: 196
  • OPEN
    Title: Effectiveness of imaging genetics analysis to explain degree of depression in Parkinson’s disease
    Journal Name: PLOS ONE
    Publisher: Public Library of Science (PLoS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1371/journal.pone.0211699
    Citation Count: 8
  • OPEN
    Title: Altered functional network topology correlates with clinical measures in very early-stage, drug-naïve Parkinson's disease
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: publisher-specific-oa
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.02.001
    Citation Count: 20
  • OPEN
    Title: Neural correlates of distinct cognitive phenotypes in early Parkinson's disease
    Journal Name: Journal of the Neurological Sciences
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.jns.2019.02.013
    Citation Count: 10
  • OPEN
    Title: Genome-wide analyses as part of the international FTLD-TDP whole-genome sequencing consortium reveals novel disease risk factors and increases support for immune dysfunction in FTLD
    Journal Name: Acta Neuropathologica
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1007/s00401-019-01962-9
    Citation Count: 94
  • OPEN
    Title: An estimate of the total number of true human miRNAs
    Journal Name: Nucleic Acids Research
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1093/nar/gkz097
    Citation Count: 443
  • RESTRICTED
    Title: A Systematic Review and Case Series of Ziprasidone for Psychosis in Parkinson’s Disease
    Journal Name: Journal of Parkinson's Disease
    Publisher: IOS Press
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.3233/jpd-181448
    Citation Count: 11
  • OPEN
    Title: l ‐3,4‐dihydroxyphenylalanine ( l ‐DOPA) modulates brain iron, dopaminergic neurodegeneration and motor dysfunction in iron overload and mutant alpha‐synuclein mouse models of Parkinson's disease
    Journal Name: Journal of Neurochemistry
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: publisher-specific, author manuscript
    DOI - Digital Object Identifier: 10.1111/jnc.14676
    Citation Count: 30
  • OPEN
    Title: Alzheimer’s disease phospholipase C-gamma-2 (PLCG2) protective variant is a functional hypermorph
    Journal Name: Alzheimer's Research & Therapy
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s13195-019-0469-0
    Citation Count: 113
  • OPEN
    Title: The G2019S variant of leucine-rich repeat kinase 2 (LRRK2) alters endolysosomal trafficking by impairing the function of the GTPase RAB8A
    Journal Name: Journal of Biological Chemistry
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1074/jbc.ra118.005008
    Citation Count: 64
Filters
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.